Pitt Shield

Focused ultrasound blood brain barrier opening mediated delivery of MRI-visible albumin nanoclusters to the rat brain for localized drug delivery with temporal control.

Authors: Rich MC, Sherwood J, Bartley AF, Whitsitt QA, Lee M, Willoughby WR, Dobrunz LE, Bao Y, Lubin FD, Bolding M

There is an ongoing need for noninvasive tools to manipulate brain activity with molecular, spatial and temporal specificity. Here we have investigated the use of MRI-visible, albumin-based nanoclusters for noninvasive, localized and temporally specific drug delivery to the rat brain. We demonstrated that IV injected nanoclusters could be deposited into target brain regions via focused ultrasound facilitated blood brain barrier opening. We showed that nanocluster location could be confirmed in vivo with MRI. Additionally, following confirmation of nanocluster delivery, release of the nanocluster payload into brain tissue can be triggered by a second focused ultrasound treatment performed without circulating microbubbles. Release of glutamate from nanoclusters in vivo caused enhanced c-Fos expression, indicating that the loading capacity of the nanoclusters is sufficient to induce neuronal activation. This novel technique for noninvasive stereotactic drug delivery to the brain with temporal specificity could provide a new way to study brain circuits in vivo preclinically with high relevance for clinical translation.

Introduction

Purpose Drug delivery with BBB opening
Study Objective To investigate MRI-visible, albumin-based nanoclusters combined with focused ultrasound for noninvasive, localized, and temporally specific drug delivery to the rat brain.
Animal model / Human subject Rat (Rattus norvegicus); strain: Sprague Dawley; age: not specified; sex: male
Disease model Healthy
MRI or image guidance method MRI-guided (MRI-visible albumin nanoclusters used to confirm FUS targeting/in vivo location)
Targeted brain region(s) Hippocampus
Cargo name and characteristics Glutamate — loaded albumin nanoclusters
Route of administration intravenous

Outcomes and Safety

Summary of Outcomes FUS induced BBB opening enabled MRI-visible albumin nanoclusters to accumulate in brain, subsequent microbubble-free FUS triggered glutamate release which enhanced c-Fos expression
Duration of biological effect 90 minutes
Safety-related matter No safety issues or adverse effects were reported in the provided text.

Brain Region

Ultrasound Parameters

Ultrasound instrument Single element FUS tranducer (FUS Instruments, Toronto, ON, Canada)
FUS Frequency 1.1 MHz
FUS Pressure 0.30 Mpa
FUS Mode pulsed
Pulse duration 10 ms
Duration of a single FUS session 2 minutes
Focal Characteristics Focal depth: 60 mm, Focal length: None, Aperture size: 75 mm
Treatment frequency single session

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search